These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 22655679)

  • 1. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomedical nanotechnology for cancer.
    Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
    Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical nanomaterials for imaging-guided cancer therapy.
    Huang Y; He S; Cao W; Cai K; Liang XJ
    Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunable nanostructures as photothermal theranostic agents.
    Young JK; Figueroa ER; Drezek RA
    Ann Biomed Eng; 2012 Feb; 40(2):438-59. PubMed ID: 22134466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotheranostics for personalized medicine.
    Mura S; Couvreur P
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in basic and clinical nanomedicine.
    Morrow KJ; Bawa R; Wei C
    Med Clin North Am; 2007 Sep; 91(5):805-43. PubMed ID: 17826104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral inorganic nanoparticles: origin, optical properties and bioapplications.
    Xia Y; Zhou Y; Tang Z
    Nanoscale; 2011 Apr; 3(4):1374-82. PubMed ID: 21301709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyconanoparticles: multifunctional nanomaterials for biomedical applications.
    García I; Marradi M; Penadés S
    Nanomedicine (Lond); 2010 Jul; 5(5):777-92. PubMed ID: 20662648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current molecular and emerging nanobiotechnology approaches for the detection of microbial pathogens.
    Theron J; Eugene Cloete T; de Kwaadsteniet M
    Crit Rev Microbiol; 2010 Nov; 36(4):318-39. PubMed ID: 20879848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.